Matthew Dufault
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Matthew Dufault has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anna Shrifteylik
School of Pharmacy, Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA
1 shared publication - Bobban Subhadra
BIOM Pharmaceutical Corporation, Sarasota, FL 34234, USA
1 shared publication - Daniel Austin
School of Pharmacy, Lake Erie College of Osteopathic Medicine, 1858 West Grandview Boulevard, Erie, Pennsylvania 16509, United States
1 shared publication - Morgan Maiolini
CVS Health, Philadelphia, PA 17601, USA
1 shared publication - Purushottam Lamichhane
LECOM School of Dental Medicine, 4800 Lakewood Ranch Blvd, Bradenton, FL 34211, USA
1 shared publication - Rahul R. Deshmukh
College of Pharmacy, Midwestern University, Glendale, AZ 85308, USA
1 shared publication
Latest Publications
- Open Access
A Current Review on the Role of Prebiotics in Colorectal Cancer
Colorectal cancer (CRC) is one of the leading causes of death in the United States and worldwide. Recent evidence has corroborated a strong correlation between poor diet and the development of CRC, and further research is being conducted to investigate the association between intestinal microbiome and the development of cancer. New studies have established links with certain foods and synthetic food compounds that may be effective in reducing the risk for carcinogenesis by providing protection against cancer cell proliferation and antagonizing oncogenic pathways. Prebiotics are gaining popularity as studies have demonstrated chemo-preventive as well as anticancer potential of prebiotics. This paper aims to discuss the wide definition and scope of prebiotics by reviewing the studies that provide insights into their effects on human health in the context of colorectal cancer.
Open AccessA Current Review on the Role of Prebiotics in Colorectal Cancer
Colorectal cancer (CRC) is one of the leading causes of death in the United States and worldwide. Recent evidence has corroborated a strong correlation between poor diet and the development of CRC, and further research is being conducted to investigate the association between intestinal microbiome and the development of cancer. New studies have established links with certain foods and synthetic food compounds that may be effective in reducing the risk for carcinogenesis by providing protection against cancer cell proliferation and antagonizing oncogenic pathways. Prebiotics are gaining popularity as studies have demonstrated chemo-preventive as well as anticancer potential of prebiotics. This paper aims to discuss the wide definition and scope of prebiotics by reviewing the studies that provide insights into their effects on human health in the context of colorectal cancer.